134 related articles for article (PubMed ID: 19186352)
1. HIV seropositivity predicts longer duration of stay and rehospitalization among nonbacteremic febrile injection drug users with skin and soft tissue infections.
Hsieh YH; Rothman RE; Bartlett JG; Yang S; Kelen GD
J Acquir Immune Defic Syndr; 2008 Dec; 49(4):398-405. PubMed ID: 19186352
[TBL] [Abstract][Full Text] [Related]
2. Impact of HIV status on outcome of infectious complications in intravenous drug users.
Mertz D; Viktorin N; Wolbers M; Flückiger U; Battegay M
J Acquir Immune Defic Syndr; 2009 Aug; 51(4):506-7; author reply 507-8. PubMed ID: 19590290
[No Abstract] [Full Text] [Related]
3. Emergency department utilization among a cohort of HIV-positive injecting drug users in a Canadian setting.
Fairbairn N; Milloy MJ; Zhang R; Lai C; Grafstein E; Kerr T; Wood E
J Emerg Med; 2012 Aug; 43(2):236-43. PubMed ID: 21719229
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and microbiology of skin and soft tissue infections.
Esposito S; Noviello S; Leone S
Curr Opin Infect Dis; 2016 Apr; 29(2):109-15. PubMed ID: 26779772
[TBL] [Abstract][Full Text] [Related]
5. Clinical profile of injection drug users presenting to the ED.
Kievlan DR; Gukasyan M; Gesch J; Rodriguez RM
Am J Emerg Med; 2015 May; 33(5):674-6. PubMed ID: 25744147
[TBL] [Abstract][Full Text] [Related]
6. Hospital utilization and costs in a cohort of injection drug users.
Palepu A; Tyndall MW; Leon H; Muller J; O'Shaughnessy MV; Schechter MT; Anis AH
CMAJ; 2001 Aug; 165(4):415-20. PubMed ID: 11531049
[TBL] [Abstract][Full Text] [Related]
7. Skin and soft tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus.
Graber C
BETA; 2007; 19(4):20-6. PubMed ID: 18069153
[TBL] [Abstract][Full Text] [Related]
8. Type and location of injection drug use-related soft tissue infections predict hospitalization.
Takahashi TA; Merrill JO; Boyko EJ; Bradley KA
J Urban Health; 2003 Mar; 80(1):127-36. PubMed ID: 12612102
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors Associated With Skin and Soft Tissue Infections Among Hospitalized People Who Inject Drugs.
Phillips KT; Anderson BJ; Herman DS; Liebschutz JM; Stein MD
J Addict Med; 2017; 11(6):461-467. PubMed ID: 28767536
[TBL] [Abstract][Full Text] [Related]
10. Compliance to antibiotic guidelines leads to more appropriate use of antibiotics in skin and soft tissue infections in injecting drug users.
Nymoen Aasbrenn M; Skeie I; Berild D
Infect Dis (Lond); 2019 Aug; 51(8):570-577. PubMed ID: 31144548
[No Abstract] [Full Text] [Related]
11. Low yield of blood and wound cultures in patients with skin and soft-tissue infections.
Torres J; Avalos N; Echols L; Mongelluzzo J; Rodriguez RM
Am J Emerg Med; 2017 Aug; 35(8):1159-1161. PubMed ID: 28592371
[TBL] [Abstract][Full Text] [Related]
12. Staphylococcus aureus infections in injection drug users: risk factors and prevention strategies.
Bassetti S; Battegay M
Infection; 2004 Jun; 32(3):163-9. PubMed ID: 15188077
[TBL] [Abstract][Full Text] [Related]
13. [Injection site abscesses in intravenous drug users. Frequency of associated complications related to localisation].
Pfefferkorn U; Viehl CT; Bassetti S; Wolff T; Oertli D
Chirurg; 2005 Nov; 76(11):1053-7. PubMed ID: 15971034
[TBL] [Abstract][Full Text] [Related]
14. Hospitalist perspective on the treatment of skin and soft tissue infections.
Amin AN; Cerceo EA; Deitelzweig SB; Pile JC; Rosenberg DJ; Sherman BM
Mayo Clin Proc; 2014 Oct; 89(10):1436-51. PubMed ID: 24974260
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study.
Murphy EL; DeVita D; Liu H; Vittinghoff E; Leung P; Ciccarone DH; Edlin BR
Clin Infect Dis; 2001 Jul; 33(1):35-40. PubMed ID: 11389492
[TBL] [Abstract][Full Text] [Related]
16. Trends and factors associated with initial and recurrent methicillin-resistant Staphylococcus aureus (MRSA) skin and soft-tissue infections among HIV-infected persons: an 18-year study.
Vyas KJ; Shadyab AH; Lin CD; Crum-Cianflone NF
J Int Assoc Provid AIDS Care; 2014; 13(3):206-13. PubMed ID: 23603632
[TBL] [Abstract][Full Text] [Related]
17. Severe soft tissue infections.
Napolitano LM
Infect Dis Clin North Am; 2009 Sep; 23(3):571-91. PubMed ID: 19665084
[TBL] [Abstract][Full Text] [Related]
18. Appropriateness of antibiotic management of uncomplicated skin and soft tissue infections in hospitalized adult patients.
Walsh TL; Chan L; Konopka CI; Burkitt MJ; Moffa MA; Bremmer DN; Murillo MA; Watson C; Chan-Tompkins NH
BMC Infect Dis; 2016 Nov; 16(1):721. PubMed ID: 27899072
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for HIV seropositivity in a sample of drug users in drug treatment in Ho Chi Minh City, Vietnam.
Tran SD; Williams AB; Truong HT; Do NH
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):283-7. PubMed ID: 9495230
[TBL] [Abstract][Full Text] [Related]
20. Recurrent skin and soft tissue infections in HIV-infected patients during a 5-year period: incidence and risk factors in a retrospective cohort study.
Hemmige V; McNulty M; Silverman E; David MZ
BMC Infect Dis; 2015 Oct; 15():455. PubMed ID: 26503616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
